Cart
sales@molnova.com
HO-3867
CAS No. 1172133-28-6
HO-3867( HO 3867 | HO3867 )
Catalog No. M10576 CAS No. 1172133-28-6
A synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 63 | Get Quote |
|
| 5MG | 87 | Get Quote |
|
| 10MG | 115 | Get Quote |
|
| 25MG | 237 | Get Quote |
|
| 50MG | 380 | Get Quote |
|
| 100MG | 605 | Get Quote |
|
| 200MG | 843 | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameHO-3867
-
NoteResearch use only, not for human use.
-
Brief DescriptionA synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs.
-
DescriptionA synthetic curcuminoid that selectively inhibits STAT3 phosphorylation, transcription, and DNA binding without affecting the expression of other active STATs; induces G2-M cell cycle arrest in A2780 cells by modulating cell cycle regulatory molecules p53, p21, p27, CDK 2, and cyclin, and promotes apoptosis, inhibits pSTAT3 (Tyr705 and Ser727) and JAK1 and increases apoptotic markers cleaved caspase-3 and PARP in xenograft tumor tissues.
-
In Vitro——
-
In Vivo——
-
SynonymsHO 3867 | HO3867
-
PathwayJAK/STAT Signaling
-
TargetSTAT
-
RecptorSTAT3
-
Research AreaCancer
-
Indication——
Chemical Information
-
CAS Number1172133-28-6
-
Formula Weight464.5468
-
Molecular FormulaC28H30F2N2O2
-
Purity>98% (HPLC)
-
SolubilityDMSO: ≥ 32 mg/mL
-
SMILESO=C1/C(CN(CC2=CC(C)(C)N(O)C2(C)C)C/C1=C\C3=CC=C(F)C=C3)=C/C4=CC=C(F)C=C4
-
Chemical Name4-Piperidinone, 1-[(2,5-dihydro-1-hydroxy-2,2,5,5-tetramethyl-1H-pyrrol-3-yl)methyl]-3,5-bis[(4-fluorophenyl)methylene]-, (3E,5E)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Rath KS, et al. Cancer Res. 2014 Apr 15;74(8):2316-27.
2. Selvendiran K, et al. Mol Cancer Ther. 2010 May;9(5):1169-79.
3. Selvendiran K, et al. Cancer Biol Ther. 2011 Nov 1;12(9):837-45.
molnova catalog
related products
-
Indirubin E804
An indirubin derivative that potently blocks constitutive STAT3 signaling in human breast and prostate cancer cells.
-
Erasin
A potent, selective STAT3 inhibitor with IC50 of 9.7 uM, inhibits tyrosine phosphorylation of STAT3 with selectivity over STAT5 and STAT1 in cell-based assays.
-
LLL-12
A nonpeptide, cell-permeable STAT3 inhibitor that binds directly to the pTyr705 binding site of the STAT3 monomer.
